A Two-Part, Phase 1 Study to Evaluate Pharmacokinetics and Pharmacodynamics of Multiple Dose CC-90001 and to Evaluate the Effects of Food and Formulation on Pharmacokinetics of Single Dose CC-90001 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2015
At a glance
- Drugs CC 90001 (Primary)
- Indications Hepatic fibrosis; Idiopathic pulmonary fibrosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Celgene Corporation
- 08 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 24 Dec 2014 New trial record